Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
Clinical trial NCT02925650 · COMPLETED
Trial details
- NCT number
- NCT02925650
- Sponsor
- Annovis Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2021-12-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.